
China's Duality Biotherapeutics shares rise more than double in Hong Kong debut
SYDNEY: Duality Biotherapeutics stock more than doubled on its Hong Kong debut on Tuesday, achieving the best first-day trading performance following an IPO in the city in four years. The Chinese biotech firm raised $213 million in an initial public …